Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth

Clinical Epigenetics, Mar 2018

Yuzhu Wang, Tao He, James G. Herman, Enqiang Linghu, Yunsheng Yang, François Fuks, Fuyou Zhou, Linjie Song, Mingzhou Guo

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1186%2Fs13148-018-0467-2.pdf

Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth

Wang et al. Clinical Epigenetics Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth Yuzhu Wang 1 2 3 Tao He 2 3 James G. Herman 0 3 Enqiang Linghu 2 3 Yunsheng Yang 2 3 François Fuks 3 7 Fuyou Zhou 3 6 Linjie Song 3 4 5 Mingzhou Guo 2 3 0 The Hillman Cancer Center, University of Pittsburgh Cancer Institute , Pittsburgh, PA 15213 , USA 1 Department of Geriatric Digestive System, Chinese PLA Navy General Hospital , 6 Fucheng Road, Beijing 100048 , China 2 Department of Gastroenterology & Hepatology, Chinese PLA General Hospital , 28 Fuxing Road, Beijing 100853 , China 3 Vedeld HM, Andresen K , Eilertsen IA, Nesbakken A, Seruca R, Gladhaug IP, Thiis-Evensen E, Rognum TO, Boberg KM, Lind GE: The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers. Int J Cancer 2015, 136:844-853 4 Medical College of NanKai University , Tianjin 300071 , China 5 Department of General Surgery, Chinese PLA General Hospital , 28 Fuxing Road, Beijing 100853 , China 6 Department of Thoracic Surgery, Anyang Tumor Hospital , Anyang 455000 , China 7 Laboratory of Cancer Epigenetics, Free University of Brussels (U.L.B.) , 1070 Brussels , Belgium - Correction After publication of the original article [1], it came to the authors’ attention that a reference was omitted from the Background. The reference should have been inserted as [16] and is the following: The last paragraph of the Background should have read as follows: “Zinc finger protein 331 (ZNF331) was first identified from thyroid tumors [12]. It is also known as RITA (rearranged in thyroid adenoma), ZNF361, and ZNF463 [13]. The ZNF331 gene is located at chromosome 19q13.42, a region in which loss of heterozygosity (LOH) was detected in prostate cancer [14]. In our previous study, we found that the ZNF331 gene is frequently methylated in human esophageal squamous cell cancer (ESCC) and it serves as a tumor suppressor in ESCC [15]. It was reported that the high methylation frequency of ZNF331 was found in some types of gastrointestinal cancer including CRC [16]. But the function of ZNF331 in human CRC remains unclear. In this study, we analyzed the epigenetic regulation and the function of ZNF331 in human CRC.”


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1186%2Fs13148-018-0467-2.pdf

Yuzhu Wang, Tao He, James G. Herman, Enqiang Linghu, Yunsheng Yang, François Fuks, Fuyou Zhou, Linjie Song, Mingzhou Guo. Correction to: Methylation of ZNF331 is an independent prognostic marker of colorectal cancer and promotes colorectal cancer growth, Clinical Epigenetics, 2018, 36, DOI: 10.1186/s13148-018-0467-2